These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10576529)

  • 61. 5. Prevention or Delay of Type 2 Diabetes:
    American Diabetes Association
    Diabetes Care; 2018 Jan; 41(Suppl 1):S51-S54. PubMed ID: 29222376
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diabetes: Strategies to prevent the type 2 diabetes mellitus epidemic.
    Robertson RP; Kendall DM; Seaquist ER
    Nat Rev Endocrinol; 2010 Mar; 6(3):128-9. PubMed ID: 20173772
    [No Abstract]   [Full Text] [Related]  

  • 63. Treatment options following metformin in primary prevention populations with type 2 diabetes: which is the right road to take?
    Koufakis T; Papanas N; Zebekakis P; Kotsa K
    Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1189-1192. PubMed ID: 34120551
    [No Abstract]   [Full Text] [Related]  

  • 64. Striving for a more active community. Lessons from the diabetes prevention program and beyond.
    Kriska A
    Am J Prev Med; 2002 May; 22(4 Suppl):6-7. PubMed ID: 11985930
    [No Abstract]   [Full Text] [Related]  

  • 65. An update on the pharmacogenomics of metformin: progress, problems and potential.
    Todd JN; Florez JC
    Pharmacogenomics; 2014 Mar; 15(4):529-39. PubMed ID: 24624919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [[Type 2 diabetes: metformin a first line. Where are the proofs]?].
    Boussageon R
    Rev Prat; 2016 Apr; 66(4):355-357. PubMed ID: 30512692
    [No Abstract]   [Full Text] [Related]  

  • 67. Metformin: current clinical applications in nondiabetic patients with cancer.
    Chen K; Li Y; Guo Z; Zeng Y; Zhang W; Wang H
    Aging (Albany NY); 2020 Feb; 12(4):3993-4009. PubMed ID: 32074084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Why to choose metformin as first line treatment in type2 diabetes? The answer is simple!].
    Grimaldi A
    Rev Prat; 2016 May; 66(5):475-476. PubMed ID: 30512562
    [No Abstract]   [Full Text] [Related]  

  • 69. Metformin associated with better cardiovascular outcomes than other glycaemic therapies.
    Bloomgarden ZT
    Evid Based Med; 2014 Jun; 19(3):103. PubMed ID: 24393715
    [No Abstract]   [Full Text] [Related]  

  • 70. [Not Available].
    Alvarsson M; Östgren CJ
    Lakartidningen; 2018 Feb; 115():. PubMed ID: 29461568
    [No Abstract]   [Full Text] [Related]  

  • 71. Association of Metformin With the Development of Age-Related Macular Degeneration in the Diabetes Prevention Program Outcomes Study.
    Asensio-Sánchez VM
    JAMA Ophthalmol; 2023 Jul; 141(7):696. PubMed ID: 37227707
    [No Abstract]   [Full Text] [Related]  

  • 72. Association of Metformin With the Development of Age-related Macular Degeneration in the Diabetes Prevention Program Outcomes Study-Reply.
    Domalpally A; Pan Q; Chew EY
    JAMA Ophthalmol; 2023 Jul; 141(7):697. PubMed ID: 37227711
    [No Abstract]   [Full Text] [Related]  

  • 73. Metformin and mortality after surgery: a systematic review and meta-analysis.
    Jones TF; Iakovou D; Makariou N; Fowler AJ; Ackland GL
    Br J Anaesth; 2022 Apr; 128(4):e277-e279. PubMed ID: 35090726
    [No Abstract]   [Full Text] [Related]  

  • 74. Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.
    Dziedzic A; Saluk-Bijak J; Miller E; Bijak M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825027
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of type 2 diabetes: what is it really?
    Buchanan TA
    Diabetes Care; 2003 Apr; 26(4):1306-8. PubMed ID: 12663614
    [No Abstract]   [Full Text] [Related]  

  • 76. The prevention or delay of type 2 diabetes.
    Sherwin RS; Anderson RM; Buse JB; Chin MH; Eddy D; Fradkin J; Ganiats TG; Ginsberg H; Kahn R; Nwankwo R; Rewers M; Schlessinger L; Stern M; Vinicor F; Zinman B;
    Diabetes Care; 2003 Jan; 26 Suppl 1():S62-9. PubMed ID: 12502620
    [No Abstract]   [Full Text] [Related]  

  • 77. Cardiovascular Corner: Low Lipids, Metformin, and Plant-Based Diets.
    Abbasi J
    JAMA; 2019 Jul; 322(1):15-16. PubMed ID: 31188400
    [No Abstract]   [Full Text] [Related]  

  • 78. The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis.
    Engels CC; de Glas NA; Sajet A; Bastiaannet E; Smit VT; Kuppen PJ; Seynaeve C; van de Velde CJ; Liefers GJ
    Mol Oncol; 2016 Apr; 10(4):509-16. PubMed ID: 26706833
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia.
    Zaki NF; Sulaiman AS; Gillani WS
    Int Arch Med; 2010 Nov; 3():34. PubMed ID: 21092333
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Why combine diet and physical activity in the same international research society?
    Baranowski T
    Int J Behav Nutr Phys Act; 2004 Feb; 1(1):2. PubMed ID: 15171787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.